Laurus Labs (LAURUSLABS) AGM 2026 summary

Opening remarks and agenda

• Meeting conducted via audio-visual means, with e-voting and video conferencing provided for shareholder participation.

• Statutory registers and AGM documents available electronically; quorum confirmed as per legal requirements.

• Chairman introduced board members, auditors, and confirmed the meeting was duly constituted.

Financial performance review

• Gross margins exceeded 60%, EBITDA margins around 28%, and net debt/EBITDA at 1.3.

• Return on equity and capital employed both healthy at about 17%.

• CDMO revenue continued to grow, supporting overall company growth.

• Profit for 2026 reached INR 889 crore, up from INR 828 crore in 2022.

Board and executive committee updates

• Board included executive and independent directors joining from multiple locations globally.

• Two directors were unable to attend due to preoccupations.